Search Results | The Journal of Immunology | American Association of Immunologists

1-20 of 37

Sort by

Sort Order Select

Journal Articles

CBLB Deficiency in Human CD4⁺ T Cells Results in Resistance to T Regulatory Suppression through Multiple Mechanisms

Jing Song, Warren Anderson, Alex Hu, Kazushige Obata-Ninomiya, Steven F. Ziegler, David J. Rawlings, Jane H. Buckner

J Immunol (2022) 209 (7): 1260–1271.

DOI: https://doi.org/10.4049/jimmunol.2200219

Published: 01 October 2022

View article

Add to Citation Manager

Includes: Supplementary data

Journal Articles

CD8 T cell exhaustion is reduced in subjects with autoimmune-associated DR4 risk alleles

Sarah Alice Long, Britta Jones, Valerie Wall, Virginia Muir, Alyssa Ylescupidez, Hannes Uchtenhagen, Peter S Linsley, Jane H Buckner

J Immunol (2022) 208 (1_Supplement): 108.06.

DOI: https://doi.org/10.4049/jimmunol.208.Supp.108.06

Published: 01 May 2022

View article

Add to Citation Manager

Journal Articles

IgA and FcαR are critical components of plasmacytoid DC response to autoantibody-containing immune complexes in SLE.

Hayley R Waterman, Matthew Duffort, Sylvia Posso, Jane H Buckner, Jessica A Hamerman

J Immunol (2022) 208 (1_Supplement): 108.19.

DOI: https://doi.org/10.4049/jimmunol.208.Supp.108.19

Published: 01 May 2022

View article

Add to Citation Manager

Journal Articles

Cutting Edge: Effect of Disease-Modifying Therapies on SARS-CoV-2 Vaccine–Induced Immune Responses in Multiple Sclerosis Patients

In Special Collection:

COVID-19, SARS, and MERS Articles

Yevgeniy Yuzefpolskiy, Peter Morawski, Mitch Fahning, Cate Speake, Sandra Lord, Anu Chaudhary, Chihiro Morishima, Mark H. Wener, Mariko Kita, Lucas McCarthy, Jane H. Buckner, Daniel J. Campbell, Estelle Bettelli

J Immunol (2022) 208 (7): 1519–1524.

DOI: https://doi.org/10.4049/jimmunol.2101142

Published: 01 April 2022

View article

Add to Citation Manager

Includes: Supplementary data

Journal Articles

Fewer LAG-3⁺ T Cells in Relapsing-Remitting Multiple Sclerosis and Type 1 Diabetes

Britta E. Jones, Megan D. Maerz, Henry T. Bahnson, Ashwin Somasundaram, Lucas H. McCarthy, Cate Speake, Jane H. Buckner

J Immunol (2022) 208 (3): 594–602.

DOI: https://doi.org/10.4049/jimmunol.2100850

Published: 01 February 2022

View article

Add to Citation Manager

Includes: Supplementary data

Journal Articles

The Autoimmune Risk R262W Variant of the Adaptor SH2B3 Improves Survival in Sepsis

Eric J. Allenspach, Nicholas J. Shubin, Karen Cerosaletti, Carmen Mikacenic, Jacquelyn A. Gorman, Matthew A. MacQuivey, Aaron B. I. Rosen, Andrew E. Timms, Michelle N. Wray-Dutra, Kerri Niino, Denny Liggitt, Mark M. Wurfel, Jane H. Buckner, Adrian M. Piliponsky, David J. Rawlings

J Immunol (2021) 207 (11): 2710–2719.

DOI: https://doi.org/10.4049/jimmunol.2100454

Published: 01 December 2021

View article

Add to Citation Manager

Includes: Supplementary data

Journal Articles

Generation of islet antigen-specific engineered Treg for use in T1D therapy via homology-directed gene editing of conventional CD4⁺ T cells

Soo Jung Yang, Akhilesh Singh, Peter Cook, Yuchi Honaker, Tori Tappen, Kelsey Mauk, Jessica Smith, Karen Sommer, David J Rawlings, Jane H Buckner

J Immunol (2020) 204 (1_Supplement): 237.30.

DOI: https://doi.org/10.4049/jimmunol.204.Supp.237.30

Published: 01 May 2020

View article

Add to Citation Manager

Journal Articles

Heightened levels of antimicrobial response factors in patients with systemic lupus erythematosus

Prathapan Ayyappan, Robert Z Harms, Jane H Buckner, Nora E Sarvetnick

J Immunol (2019) 202 (1_Supplement): 178.5.

DOI: https://doi.org/10.4049/jimmunol.202.Supp.178.5

Published: 01 May 2019

View article

Add to Citation Manager

Journal Articles

Autoantibodies against Neurologic Antigens in Nonneurologic Autoimmunity

Panos Stathopoulos, Anne Chastre, Patrick Waters, Sarosh Irani, Miriam L. Fichtner, Erik S. Benotti, Joel M. Guthridge, Jennifer Seifert, Richard J. Nowak, Jane H. Buckner, V. Michael Holers, Judith A. James, David A. Hafler, Kevin C. O’Connor

J Immunol (2019) 202 (8): 2210–2219.

DOI: https://doi.org/10.4049/jimmunol.1801295

Published: 15 April 2019

View article

Add to Citation Manager

Includes: Supplementary data

Journal Articles

Abatacept Targets T Follicular Helper and Regulatory T Cells, Disrupting Molecular Pathways That Regulate Their Proliferation and Maintenance

Simon Glatigny, Barbara Höllbacher, Samantha J. Motley, Cathy Tan, Christian Hundhausen, Jane H. Buckner, Dawn Smilek, Samia J. Khoury, Linna Ding, Tielin Qin, Jorge Pardo, Gerald T. Nepom, Laurence A. Turka, Kristina M. Harris, Daniel J. Campbell, Estelle Bettelli

J Immunol (2019) 202 (5): 1373–1382.

DOI: https://doi.org/10.4049/jimmunol.1801425

Published: 01 March 2019

View article

Add to Citation Manager

Includes: Supplementary data

Journal Articles

Stacking the Deck: Studies of Patients with Multiple Autoimmune Diseases Propelled Our Understanding of Type 1 Diabetes as an Autoimmune Disease

In Special Collection:

Pillars of Immunology

Jane H. Buckner, Carla J. Greenbaum

J Immunol (2017) 199 (9): 3011–3013.

DOI: https://doi.org/10.4049/jimmunol.1701299

Published: 01 November 2017

View article

Add to Citation Manager

Journal Articles

The Autoimmune Risk Variant PTPN22 C1858T Alters B Cell Tolerance at Discrete Checkpoints and Differentially Shapes the Naive Repertoire

Genita Metzler, Xuezhi Dai, Christopher D. Thouvenel, Socheath Khim, Tania Habib, Jane H. Buckner, David J. Rawlings

J Immunol (2017) 199 (7): 2249–2260.

DOI: https://doi.org/10.4049/jimmunol.1700601

Published: 01 October 2017

View article

Add to Citation Manager

Includes: Supplementary data

Journal Articles

Characterization of CD4+ T cells expressing an elevated interferon-stimulated gene signature in SLE patients

Sara Murray, Cate Speake, Michael J Mason, Elizabeth Whalen, Jane H Buckner, Peter S Linsley

J Immunol (2016) 196 (1_Supplement): 124.19.

DOI: https://doi.org/10.4049/jimmunol.196.Supp.124.19

Published: 01 May 2016

View article

Add to Citation Manager

Journal Articles

The IL-21 signaling pathway is enhanced in RA B cells and has the potential to alter development and cytokine production in RA B cells

Elizabeth M Dam, Jane H Buckner

J Immunol (2016) 196 (1_Supplement): 124.9.

DOI: https://doi.org/10.4049/jimmunol.196.Supp.124.9

Published: 01 May 2016

View article

Add to Citation Manager

Journal Articles

S1P₁ deletion differentially affects TH17 and Regulatory T cells

Ahmet Eken, Rebekka Duhen, Akhilesh K Singh, Mallory Fry, Jane H Buckner, Mariko Kita, Estelle Bettelli, Mohamed Oukka

J Immunol (2016) 196 (1_Supplement): 186.5.

DOI: https://doi.org/10.4049/jimmunol.196.Supp.186.5

Published: 01 May 2016

View article

Add to Citation Manager

Journal Articles

The IFIH1 A946T autoimmune risk variant exhibits enhanced signaling and promotes T1D pathogenesis

Jacquelyn A Gorman, Christian Hundhausen, John Errett, Yan Ge, Tanvi Arkatkar, Courtnee Clough, Xuezhi Dai, Socheath Khim, Mohamed Oukka, Patrick Concannon, Michael Gale, Jr, Jane H Buckner, David J Rawlings

J Immunol (2016) 196 (1_Supplement): 48.2.

DOI: https://doi.org/10.4049/jimmunol.196.Supp.48.2

Published: 01 May 2016

View article

Add to Citation Manager

Journal Articles

Reduced IL-2R signaling in T1D subjects is pervasive in the memory CD4 T effector compartment and is mediated through intrinsic mechanisms

Jerill Z Thorpe, Katharine Schwedhelm, Melissa Pickett, Carla J Greenbaum, Karen Cerosaletti, Jane H Buckner, S. Alice Long

J Immunol (2016) 196 (1_Supplement): 51.30.

DOI: https://doi.org/10.4049/jimmunol.196.Supp.51.30

Published: 01 May 2016

View article

Add to Citation Manager

Journal Articles

B cell IFN-γ receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6

Shaun W Jackson, Holly Jacobs, Tanvi Arkatkar, Elizabeth M Dam, Nicole Scharping, Nikita Kolhatkar, Baidong Hou, Jane H Buckner, David J Rawlings

J Immunol (2016) 196 (1_Supplement): 47.5.

DOI: https://doi.org/10.4049/jimmunol.196.Supp.47.5

Published: 01 May 2016

View article

Add to Citation Manager

Journal Articles

Correction: CD4⁺ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis

Florence Roan, Thomas A. Stoklasek, Elizabeth Whalen, Jerry A. Molitor, Jeffrey A. Bluestone, Jane H. Buckner, Steven F. Ziegler

J Immunol (2016) 196 (9): 3966.

DOI: https://doi.org/10.4049/jimmunol.1600364

Published: 01 May 2016

View article

Add to Citation Manager

Journal Articles

Enhanced PI3K/AKT/mTOR responses are associated with resistance to activation-induced cell death and expansion of memory CD4⁺ T cells in T1D subjects and healthy carriers of the PTPN22 risk variant

Tania J Habib, Michael S Turner, Warren Anderson, Andrew Funk, Mary Rieck, Kamal D Puri, Carla Greenbaum, S. Alice Long, Jane H. Buckner

J Immunol (2016) 196 (1_Supplement): 48.11.

DOI: https://doi.org/10.4049/jimmunol.196.Supp.48.11

Published: 01 May 2016

View article

Add to Citation Manager

NARROW

CBLB Deficiency in Human CD4⁺ T Cells Results in Resistance to T Regulatory Suppression through Multiple Mechanisms

CD8 T cell exhaustion is reduced in subjects with autoimmune-associated DR4 risk alleles

IgA and FcαR are critical components of plasmacytoid DC response to autoantibody-containing immune complexes in SLE.

Cutting Edge: Effect of Disease-Modifying Therapies on SARS-CoV-2 Vaccine–Induced Immune Responses in Multiple Sclerosis Patients

Fewer LAG-3⁺ T Cells in Relapsing-Remitting Multiple Sclerosis and Type 1 Diabetes

The Autoimmune Risk R262W Variant of the Adaptor SH2B3 Improves Survival in Sepsis

Generation of islet antigen-specific engineered Treg for use in T1D therapy via homology-directed gene editing of conventional CD4⁺ T cells

Heightened levels of antimicrobial response factors in patients with systemic lupus erythematosus

Autoantibodies against Neurologic Antigens in Nonneurologic Autoimmunity

Abatacept Targets T Follicular Helper and Regulatory T Cells, Disrupting Molecular Pathways That Regulate Their Proliferation and Maintenance

Stacking the Deck: Studies of Patients with Multiple Autoimmune Diseases Propelled Our Understanding of Type 1 Diabetes as an Autoimmune Disease

The Autoimmune Risk Variant PTPN22 C1858T Alters B Cell Tolerance at Discrete Checkpoints and Differentially Shapes the Naive Repertoire

Characterization of CD4+ T cells expressing an elevated interferon-stimulated gene signature in SLE patients

The IL-21 signaling pathway is enhanced in RA B cells and has the potential to alter development and cytokine production in RA B cells

S1P₁ deletion differentially affects TH17 and Regulatory T cells

The IFIH1 A946T autoimmune risk variant exhibits enhanced signaling and promotes T1D pathogenesis

Reduced IL-2R signaling in T1D subjects is pervasive in the memory CD4 T effector compartment and is mediated through intrinsic mechanisms

B cell IFN-γ receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6

Correction: CD4⁺ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis

Enhanced PI3K/AKT/mTOR responses are associated with resistance to activation-induced cell death and expansion of memory CD4⁺ T cells in T1D subjects and healthy carriers of the PTPN22 risk variant

Email alerts

Publications

Submit a Manuscript

General Information

Journal Services

Email alerts

Publications

Submit a Manuscript

General Information

Journal Services

This Feature Is Available To Subscribers Only